|
summary: This study on the safety and efficacy of high-dose Glatiramer Acetate in reducing MRI activity and preventing clinical relapses in people with relapsing MS concluded that this dosage is safe and well tolerated, and seems to be more effective than the lower currently approved dose.
authors: Cohen JA, Rovaris M, Goodman AD, Ladkani D, Wynn D, Filippi M; 9006 Study Group.
source: Neurology. 2007 Mar 20;68(12):939-44
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
ACE
Glatiramer
Magnetic Resonance Imaging (MRI)
Relapse
Relapsing/remitting MS
|
